Medicus Pharma Ltd. (MDCX)
0.2574
-0.01
(-5.30%)
USD |
NASDAQ |
Aug 24, 16:00
0.256
0.00 (0.00%)
After-Hours: 20:00
Medicus Pharma Debt to Equity Ratio : -12.27 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.27 |
| March 31, 2026 | 1.911 |
| December 31, 2025 | -81.05 |
| September 30, 2025 | -7.748 |
| June 30, 2025 | 1.529 |
| March 31, 2025 | 0.1372 |
| December 31, 2024 | 0.1028 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.0999 |
| June 30, 2024 | 0.0581 |
| March 31, 2024 | -0.5995 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| December 31, 2022 | -0.9392 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Aurinia Pharmaceuticals, Inc. | 0.1043 |
| enGene Therapeutics, Inc. | 0.1307 |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 0.0052 |
| Psyence Biomedical Ltd. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 19.11M |
| Total Liabilities (Quarterly) | 20.33M |
| Shareholders Equity (Quarterly) | -1.243M |
| Current Ratio | 1.566 |
| Net Debt Paydown Yield | -11.14% |